Target intelligence / Profile preview

Gut epithelial surface and mucus layer (null)

Target
null
Molecular classification
Other (refers to tissue surfaces and secreted biomaterials including glycoproteins, not a single molecular family), Mucin (primarily MUC2 and related glycoproteins), Epithelial cell surface proteins (transmembrane mucins, e.g., MUC1, MUC3, MUC13), Secretory proteins (other mucus-associated proteins: IgG Fc-binding protein, CLCA1, ZG16, AGR2, immunoglobulins)
01

Overview

Gut epithelial surfaces and mucus are structural and protective features of the gastrointestinal tract. The epithelial surface consists of a single layer of cells, primarily enterocytes and goblet cells, that are covered by a mucus layer. The mucus is a viscoelastic gel mainly made of the glycoprotein mucin—especially MUC2 in the intestine—secreted by goblet cells. This layer acts as a **physical and biochemical barrier** against pathogens, facilitates the maintenance of the microbiota, regulates immune responses, and protects underlying tissues from mechanical and chemical damage[6][4][3][7][1]. Mucus thickness and composition vary through regions of the gut, being denser and more stratified in the colon than in the small intestine[4][3][5]. Impairment or alteration of these structures is central in many gastrointestinal diseases, but they are not considered classical molecular drug targets, rather they represent complex anatomical and biochemical barriers[6][2][5][4][1]. This entry is likely **not appropriate for direct mapping as a molecular pharmacology target**. It is instead a composite of tissue anatomy and barrier biochemistry encompassing multiple molecular components. If mapping to molecular targets is needed, focus would shift to specific components such as secretory mucins (e.g., "Mucin-2" or "MUC2"), transmembrane mucins, or specific epithelial cell markers.

Other names
gut mucosal barrierintestinal epithelial surfacegastrointestinal mucosamucus layer
02

Mechanism of action

Enhance mucus secretion or hydration (lubiprostone) Anti-inflammatory effects at mucosal surfaces (aminesalicylates, corticosteroids) Modulate barrier permeability and epithelial healing (biologics in IBD) Restore ion channel function (CFTR modulators)

03

Biological functions

Barrier function (protects from pathogens, toxins, and mechanical injury)Immune response (hosts immune cells, prevents pathogen invasion)Supports and organizes gut microbiomeRegulates nutrient absorption and ion transportMaintains tissue homeostasis (moisture, pH)
04

Disease associations

Inflammation (ulcerative colitis, Crohn’s disease)Infection (facilitates barrier to or predisposes to pathogenic invasion)Cancer (chronic inflammation leads to increased risk)Other (cystic fibrosis, irritable bowel syndrome, parasitic infection)
05

Safety considerations

Excessive thinning or loss of protective mucus can increase risk of infection, inflammation, ulceration, and bleedingImpaired mucus may exacerbate exposure to toxins, immune-mediated damageOver-hydration may lead to electrolyte imbalance
06

Interacting drugs

Lubiprostone

4 more in the full profile.

07

Biomarkers

MUC2 protein/mucin levelsFecal calprotectin (inflammation)RegIIIγ (antimicrobial protein indicative of barrier integrity)CLCA1, AGR2, secreted IgA (mucus composition)

Beyond the preview

Go deeper on Gut epithelial surface and mucus layer (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut epithelial surface and mucus layer (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call